InMode Ltd vs Roivant Sciences Ltd. Common Shares — how do they compare? InMode Ltd trades at $14.14 (market cap $809.93M), while Roivant Sciences Ltd. Common Shares trades at $34.49 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 30.5× InMode Ltd's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| INMD | ROIV | |
|---|---|---|
Market Cap | $809.93M | $24.72B |
Volume | 365,490 | 6,279,442 |
Sector | Health | Health |
52-Week High | $16.62 | $41.81 |
52-Week Low | $12.76 | $16.04 |
Typical Hold Time | 29 Days | 0 Days |
Enterprise Value | $313.27M | $20.99B |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.01, up 0.14% on the day, with a bearish technical signal from moving averages and oscillators. The company reported Q2 2026 earnings of $0.35 per share, beating expectations, and maintains a strong gross profit margin of 76.52%. Recent news includes the launch of Morpheus8 Cool and an unsolicited acquisition offer from Steel Partners at $16.75 per share.
The outlook is mixed: valuation metrics like P/E of 11.63 and EV/EBITDA of 4.48 appear attractive, but declining net income and bearish technicals pose risks. Analyst consensus is divided with 45.45% buy ratings, highlighting potential upside from strategic developments against execution challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →